AMARIN CORP PLC\UK
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
AMRN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- SPACES SOUTH DOCKLANDS, BLOCK C, 0 DUBLIN 2
- Website:
- https://amarincorp.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Amarin Corporation plc is a global pharmaceutical company focused on developing and commercializing therapeutics to improve cardiovascular health. The company's core mission is to create a new paradigm in cardiovascular disease (CVD) management and reduce its impact as a leading cause of death worldwide. Its principal product is Vascepa® (icosapent ethyl), a prescription therapy used to reduce cardiovascular risk in certain patient populations. Amarin is dedicated to advancing scientific research and pursuing additional cost-effective treatments to address the needs of millions of patients at risk of heart attack or stroke.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AMARIN CORP PLC\UK filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AMARIN CORP PLC\UK
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AMARIN CORP PLC\UK via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
